Pharma

Nov 8 2017

Novartis pharma head leaves as drug maker splits operations #helvoet #pharma

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …

Sep 24 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #medicinal #chemistry

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Aug 28 2017

Free Website Builder – Easiest website builder for your website #website #builder, #web #site #builder, #web #builder, #create #a #website, #build #a #website, #easy #website #creator, #easy #website #builder, #best #website #builder, #website #maker, #free #website #builder, #free #website #maker, #search #engine #friendly, #search #engine #optimized #pages

# Ewisoft Website Builder is a powerful and easy website builder software that you can use to create a website. It is perfect for beginners and professionals. It is so easy to use, all you have to do to start a website is edit text, insert images, and drag-and-drop. You get amazing results when your website is built and maintained by Ewisoft Website Builder. Download and try it now and you will see how easy it is to build your website in only a few minutes. eCommerce Website Builder to sell products online. The eCommerce website builder software is an …

Aug 23 2017

Blue Leaf Book Scanning Service #book #scanning, #book #scanning #service, #book #scan #service, #convert #books #to #audiobook, #audiobook #builder, #audiobook #creator, #audiobook #maker #service, #document #scanning #service, #digitize #books, #book #to #pdf, #how #to #scan #books

# ONDEMAND Book Scanning Service Blue Leaf now makes book scanning affordable for the everyday consumer and small business. Our non-destructive scanning process converts virtually any size book or document to any file format, including searchable PDF, eBook (Kindle, Nook, Sony. ), audiobook (mp3), and editable text-based formats such as Word, RTF, and TXT. Our service is ideal for Log Books Textbooks Drawings Technical Documents Digitizing Valuable Books or Documents Publishing Manuals For Customer Base Republishing Out-Of-Print Books eBook Creation (Kindle, Nook, iPad, etc.) Audiobook Creation. Sample Instant Search and Indexing *please read FAQ for more information. Customer Testimonials! 3 …

May 18 2017

Novartis pharma head leaves as drug maker splits operations #lexicon #pharma

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …

Apr 22 2017

Novartis pharma head leaves as drug maker splits operations #small #pharma #companies

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …

Apr 5 2017

Novartis pharma head leaves as drug maker splits operations #cafe #pharma #novartis

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …

Mar 24 2017

Novartis pharma head leaves as drug maker splits operations #elixir #pharma

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …

Mar 14 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #martindale #pharma

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Feb 5 2017

Novartis pharma head leaves as drug maker splits operations #jrs #pharma

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …